These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36164930)

  • 1. LC-MS-MS Determination of Cytostatic Drugs on Surfaces and in Urine to Assess Occupational Exposure.
    Lema-Atán JÁ; Lendoiro E; Paniagua-González L; Cruz A; López-Rivadulla M; de-Castro-Ríos A
    J Anal Toxicol; 2023 Jan; 46(9):e248-e255. PubMed ID: 36164930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and application of a liquid chromatography coupled to mass spectrometry method for the simultaneous determination of 23 antineoplastic drugs at trace levels.
    Fleury-Souverain S; Maurin J; Guillarme D; Rudaz S; Bonnabry P
    J Pharm Biomed Anal; 2022 Nov; 221():115034. PubMed ID: 36095884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a liquid chromatography tandem mass spectrometry quantification method for 14 cytotoxic drugs in environmental samples.
    Acramel A; Chouquet T; Plé A; Sauvageon H; Mourah S; Jouenne F; Goldwirt L
    Rapid Commun Mass Spectrom; 2020 Feb; 34(4):e8594. PubMed ID: 31519060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occupational exposure to antineoplastic drugs: what about hospital sanitation personnel?
    Labrèche F; Ouellet C; Roberge B; Caron NJ; Yennek A; Bussières JF
    Int Arch Occup Environ Health; 2021 Nov; 94(8):1877-1888. PubMed ID: 34410477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wipe sampling procedure coupled to LC-MS/MS analysis for the simultaneous determination of 10 cytotoxic drugs on different surfaces.
    Nussbaumer S; Geiser L; Sadeghipour F; Hochstrasser D; Bonnabry P; Veuthey JL; Fleury-Souverain S
    Anal Bioanal Chem; 2012 Mar; 402(8):2499-509. PubMed ID: 21701850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fully validated simple new method for environmental monitoring by surface sampling for cytotoxics.
    Rossignol E; Amiand MB; Sorrieul J; Bard JM; Bobin-Dubigeon C
    J Pharmacol Toxicol Methods; 2020; 101():106652. PubMed ID: 31734280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canadian monitoring program of the surface contamination with 11 antineoplastic drugs in 122 centers.
    Delafoy C; Roussy C; Hudon AF; Cirtiu CM; Caron N; Bussières JF; Tanguay C
    J Oncol Pharm Pract; 2023 Mar; 29(2):338-347. PubMed ID: 35018847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canadian monitoring program of the surface contamination with 11 antineoplastic drugs in 124 centers.
    Pinet E; Cirtiu CM; Caron N; Bussières JF; Tanguay C
    J Oncol Pharm Pract; 2024 Jan; 30(1):19-29. PubMed ID: 37021440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multianalyte determination of 24 cytostatics and metabolites by liquid chromatography-electrospray-tandem mass spectrometry and study of their stability and optimum storage conditions in aqueous solution.
    Negreira N; Mastroianni N; López de Alda M; Barceló D
    Talanta; 2013 Nov; 116():290-9. PubMed ID: 24148406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of an innovative high-throughput liquid chromatography-tandem mass spectrometry method for simultaneous analysis of 18 hazardous drugs to rule out accidental acute chemotherapy exposures in health care workers.
    Shu P; Zhao T; Wen B; Mendelsohn-Victor K; Sun D; Friese CR; Pai MP
    J Oncol Pharm Pract; 2020 Jun; 26(4):794-802. PubMed ID: 31483750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenicity assessment of environmental contaminations in a hospital centralized reconstitution unit.
    Chouquet T; Acramel A; Sauvageon H; Plé A; Jourdan N; Madelaine I; Faure P; Mourah S; Goldwirt L
    Ecotoxicol Environ Saf; 2018 Dec; 165():174-181. PubMed ID: 30195999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of an Environmental Monitoring to Assess the Practices and Control the Risk of Occupational Exposure to Cyclophosphamide in Two Sites of a French Comprehensive Cancer Center.
    Acramel A; Fouque J; Blondeel-Gomes S; Huguet S; Rezai K; Madar O; Escalup L
    Ann Work Expo Health; 2022 Nov; 66(9):1215-1223. PubMed ID: 35596678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous determination of a selected group of cytostatic drugs in water using high-performance liquid chromatography-triple-quadrupole mass spectrometry.
    Martín J; Camacho-Muñoz D; Santos JL; Aparicio I; Alonso E
    J Sep Sci; 2011 Nov; 34(22):3166-77. PubMed ID: 22012931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A highly sensitive UHPLC-MS/MS method for urine biological monitoring of occupational exposure to anthracycline antineoplastic drugs and routine application.
    Villa A; Tremolet K; Martinez B; Da Silva Cacao O; Atgé B; Ducint D; Titier-Debeaupuis K; Verdun-Esquer C; Molimard M; Canal-Raffin M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Nov; 1156():122305. PubMed ID: 32987297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proposals of guidance values for surface contamination by antineoplastic drugs based on long term monitoring in Czech and Slovak hospitals and pharmacies.
    Bláhová L; Bláha L; Doležalová L; Kuta J; Hojdarová T
    Front Public Health; 2023; 11():1235496. PubMed ID: 37780438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous determination of cyclophosphamide, ifosfamide, doxorubicin, epirubicin and daunorubicin in human urine using high-performance liquid chromatography/electrospray ionization tandem mass spectrometry: bioanalytical method validation.
    Sottani C; Rinaldi P; Leoni E; Poggi G; Teragni C; Delmonte A; Minoia C
    Rapid Commun Mass Spectrom; 2008 Sep; 22(17):2645-59. PubMed ID: 18666202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wipe-sampling procedure optimisation for the determination of 23 antineoplastic drugs used in the hospital pharmacy.
    Guichard N; Boccard J; Rudaz S; Bonnabry P; Fleury Souverain S
    Eur J Hosp Pharm; 2021 Mar; 28(2):94-99. PubMed ID: 33608437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface contamination with nine antineoplastic drugs in 109 canadian centers; 10 years of a monitoring program.
    Chabut C; Tanguay C; Gagné S; Caron N; Bussières JF
    J Oncol Pharm Pract; 2022 Mar; 28(2):343-352. PubMed ID: 33567975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A quantitative LC-MS method to determine surface contamination of antineoplastic drugs by wipe sampling.
    Kåredal M; Jönsson R; Wetterling M; Björk B; Hedmer M
    J Occup Environ Hyg; 2022 Jan; 19(1):50-66. PubMed ID: 34723774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous LC-MS/MS bioanalysis of etoposide and paclitaxel in mouse tissues and plasma after oral administration of self-microemulsifying drug-delivery systems.
    Li D; Zhao G; Ai W; Li G; Si L; Huang J; Chen Y; Wu S
    Biomed Chromatogr; 2018 Jun; 32(6):e4192. PubMed ID: 29349799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.